Intellia Therapeutics Receives Backing of UK Health Regulator to Conduct Trial of Gene Therapy

intellia therapeutics獲得英國衛生監管機構支持進行基因治療試驗

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

登入免費觀看全文